Public recall detail

ACH-SITAGLIPTIN: May exceed established acceptable intake limit for NTTP.

2024-08-13

medium
Recall Safety notice
Quick summary

Quick summary: ACH-SITAGLIPTIN: May exceed established acceptable intake limit for NTTP.. Date: 2024-08-13.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: ACH-SITAGLIPTIN: May exceed established acceptable intake limit for NTTP.. Date: 2024-08-13.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

BrandAccord Healthcare Inc, ACH-SITAGLIPTIN
ProductACH-SITAGLIPTIN
IssueHealth products - Product safety
Recall classType I
IdentificationRA-75915

Affected products

BrandACH-SITAGLIPTIN
ProductACH-SITAGLIPTIN
DIN / NPN / authorizationDIN 02512475
Dosage formTablet
StrengthSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 25 MG
LotP2206573
BrandACH-SITAGLIPTIN
ProductACH-SITAGLIPTIN
DIN / NPN / authorizationDIN 02512483
Dosage formTablet
StrengthSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 50 MG
LotP2206574
BrandACH-SITAGLIPTIN
ProductACH-SITAGLIPTIN
DIN / NPN / authorizationDIN 02512491
Dosage formTablet
StrengthSITAGLIPTIN (SITAGLIPTIN PHOSPHATE) 100 MG
LotP2206575, P2206981

Issue

The affected lots may exceed the established acceptable intake limit for 7-nitroso-3-(trifluoromethyl)- 5,6,7,8-tetrahydro[1,2,4] triazolo-[4,3-a]pyrazine (NTTP).

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesAccord Healthcare Inc. 3535 Boulevard St-Charles, Suite 704, Kirkland, QC H9H 5B9
Published byHealth Canada
Recall classType I
Alert / recall typeHealth product recall
Identification numberRA-75915
Background{}
CompaniesAccord Healthcare Inc. 3535 Boulevard St-Charles, Suite 704, Kirkland, QC H9H 5B9
AudiencesGeneral public Healthcare Industry
Source updated2024-08-13

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...